Nissan Chemical (4021) Q1 2026 earnings summary

Executive summary

• Achieved record-high sales, operating profit, and net income in 1Q FY2025, with all metrics exceeding both year-ago and outlook figures.

• 1Q sales rose 19% year-over-year to ¥69.9 billion, operating profit up 25% to ¥18.1 billion, and net income up 20% to ¥13.9 billion.

• All business segments reported sales growth, with notable strength in Performance Materials, Agricultural Chemicals, and Trading.

• Share repurchase plan totaling ¥10.5 billion underway, with ¥1.5 billion completed in April and ¥9.0 billion planned through March 2026.

• FY2025 outlook for 1H and full year remains unchanged from May 2025 guidance.

Financial highlights

• Sales: ¥69.9 billion (+19% YoY), Operating Profit: ¥18.1 billion (+25% YoY), Net Income: ¥13.9 billion (+20% YoY).

• EBITDA increased by ¥3.4 billion to ¥21.4 billion year-over-year.

• EPS rose to ¥102.20 (+18.42 YoY).

• Free cash flow in 1Q FY2025 was ¥13.0 billion, up ¥0.5 billion YoY.

• Cash & cash equivalents at period end: ¥33.5 billion, up ¥6.1 billion from March 2025.

Outlook and guidance

• FY2025 outlook for 1H and full year, including segment guidance, remains unchanged from May 2025.

• 1Q results exceeded outlook: sales by ¥4.9 billion (+7%), operating profit by ¥1.0 billion (+6%), net income by ¥1.7 billion (+14%).

• Full-year net sales projected at ¥262.2 billion (+4.3%), operating income at ¥57.6 billion (+1.3%), and net income at ¥43.1 billion (+0.1%).

• Dividend payout ratio target set at 55% or more, with total payout ratio at 75% or more after FY2025.